MS
The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals.
In research presented at the AMIA Informatics Summit, University of Texas bioinformaticians tried a new algorithm to include epigenetic factors in predicting disease progression.
T Cell Gene Expression In Multiple Sclerosis CSF Reflects Elevated Activation, Cytotoxicity
Researchers profiled T cells in the cerebrospinal fluid of healthy individuals and multiple sclerosis patients using single-cell RNA-seq and T cell receptor sequencing.
Based in Boston with operations in Ireland and Iceland, the reorganized company is supporting COVID-19 testing and population genomics as it sheds its China division.
Johns Hopkins, NYSCF Collaborate on Stem Cell Models of Disease for Precision Medicine
The collaborators hope to establish new models of human disease using patient-derived stem cells, with support from Bloomberg Philanthropies.